GenNx360 Capital Partners has completed the sale of Novel Ingredients, a provider of natural ingredients to the supplement industry, to publicly-traded Innophos Holdings, a producer of specialty ingredients used in the food, health, nutrition and industrial markets. The total purchase price paid for Novel was $125 million in cash. This represents a 12.1x multiple of […]
